Dr. Cotropia is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Connect with other colleagues in the same hospital or clinic
- Search all U.S. specialist profiles and refer a patient
- Read the latest clinical news and earn CME/CEU credits
Office
800 Raymond Stotzer Parkway
Building 1904 Office 2106
College Station, TX 77845Phone+1 469-512-8917Fax+1 305-832-0519- Is this information wrong?
Education & Training
- University of Texas at Austin Dell Medical SchoolResidency, Internal Medicine, 1981 - 1983
- Texas Health Resources (Dallas)Residency, Internal Medicine, 1979 - 1980
- University of Texas Southwestern Medical SchoolClass of 1973
Certifications & Licensure
- CA State Medical License 1980 - 2016
- TX State Medical License 1980 - 2015
- PA State Medical License Active through 2012
Publications & Presentations
PubMed
- 4 citationsCharacterization of a novel human anti-HIV-1 gp41 IgM monoclonal antibody designated clone 37.Chuanhai Cao, Yun Bai, Mary Jolene Holloway, Rebecca L. Edgeworth, Eugene A. Jackson, Joseph Cotropia, Kenneth E. Ugen> ;DNA and Cell Biology. 2004 Dec 1
- 35 citationsPotent cross-group neutralization of primary human immunodeficiency virus isolates with monoclonal antibodies--implications for acquired immunodeficiency syndrome vacc...Flavia Ferrantelli, Moiz Kitabwalla, Robert A. Rasmussen, Chuanhai Cao, Ting-Chao Chou, Hermann Katinger, Gabriela Stiegler, Lisa A. Cavacini, Yun Bai, Joseph Cotropia...> ;The Journal of Infectious Diseases. 2004 Jan 1
- 8 citationsCharacterization of a novel human immunodeficiency virus type 1 neutralizable epitope within the immunodominant region of gp41.Monica Viveros, Chad A. Dickey, Joseph Cotropia, G. Gevorkian, Carlos Larralde, Kristina Broliden, Mikael Levi, Andrew W. O. Burgess, Chuanhai Cao, David B. Weiner, Mi...> ;Virology. 2000 Apr 25
- Join now to see all
Press Mentions
- Blue Skies; Enzolytics Inc (OTCMKTS: ENZC) BioClonetics MergerNovember 28th, 2020
- $0.0217 Price to Beat: Enzolytics Inc (OTCMKTS: ENZC); BioClonetics MergerNovember 1st, 2020
- Enzolytics, Inc. Shares BioClonetics Immunotherapeutics, Inc. Company UpdateOctober 19th, 2020
- Join now to see all
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: